Loading...

Allscripts Healthcare Solutions

Nasdaq:MDRX
Snowflake Description

Moderate growth potential with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MDRX
Nasdaq
$2B
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. The last earnings update was 46 days ago. More info.


Add to Portfolio Compare Print Invest
MDRX Share Price and Events
Price Volatility
MDRX
Industry
5yr Volatility vs Market
Related Companies

MDRX Value

 Is Allscripts Healthcare Solutions undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Allscripts Healthcare Solutions to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Allscripts Healthcare Solutions.

NasdaqGS:MDRX Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 20 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 13.2%
Perpetual Growth Rate 10-Year US Government Bond Rate 3%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqGS:MDRX
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 3%
Equity Risk Premium S&P Global 7.1%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.94
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.944 (1 + (1- 21%) (67.59%))
1.448
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.45
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.95% + (1.448 * 7.05%)
13.16%

Discounted Cash Flow Calculation for NasdaqGS:MDRX using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Allscripts Healthcare Solutions is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

NasdaqGS:MDRX DCF 1st Stage: Next 5 year cash flow forecast
2018 2019 2020 2021 2022
Levered FCF (USD, Millions) 130.80 168.11 196.37 243.80 271.45
Source Analyst x7 Analyst x7 Analyst x3 Analyst x2 Analyst x2
Present Value
Discounted (@ 13.16%)
115.59 131.28 135.51 148.68 146.29
Present value of next 5 years cash flows $677.35
NasdaqGS:MDRX DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2022 × (1 + g) ÷ (Discount Rate – g)
= $271.45 × (1 + 2.95%) ÷ (13.16% – 2.95%)
$2,736.80
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= $2,736.80 ÷ (1 + 13.16%)5
$1,474.88
NasdaqGS:MDRX Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= $677.35 + $1,474.88
$2,152.23
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $2,152.23 / 174.61
$12.33
NasdaqGS:MDRX Discount to Share Price
Calculation Result
Value per share (USD) From above. $12.33
Current discount Discount to share price of $13.86
= -1 x ($13.86 - $12.33) / $12.33
-12.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Allscripts Healthcare Solutions is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Allscripts Healthcare Solutions's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Allscripts Healthcare Solutions's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGS:MDRX PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in USD $-0.03
NasdaqGS:MDRX Share Price ** NasdaqGS (2018-08-15) in USD $13.86
United States of America Healthcare Services Industry PE Ratio Median Figure of 25 Publicly-Listed Healthcare Services Companies 49.26x
United States of America Market PE Ratio Median Figure of 7,193 Publicly-Listed Companies 18.22x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Allscripts Healthcare Solutions.

NasdaqGS:MDRX PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:MDRX Share Price ÷ EPS (both in USD)

= 13.86 ÷ -0.03

-399.37x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allscripts Healthcare Solutions is loss making, we can't compare its value to the US Healthcare Services industry average.
  • Allscripts Healthcare Solutions is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Allscripts Healthcare Solutions's expected growth come at a high price?
Raw Data
NasdaqGS:MDRX PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -399.37x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 20 Analysts
33.6%per year
United States of America Healthcare Services Industry PEG Ratio Median Figure of 17 Publicly-Listed Healthcare Services Companies 2.65x
United States of America Market PEG Ratio Median Figure of 5,693 Publicly-Listed Companies 1.59x

*Line of best fit is calculated by linear regression .

NasdaqGS:MDRX PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= -399.37x ÷ 33.6%

-11.9x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allscripts Healthcare Solutions is loss making, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Allscripts Healthcare Solutions's assets?
Raw Data
NasdaqGS:MDRX PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in USD $6.37
NasdaqGS:MDRX Share Price * NasdaqGS (2018-08-15) in USD $13.86
United States of America Healthcare Services Industry PB Ratio Median Figure of 64 Publicly-Listed Healthcare Services Companies 4.21x
United States of America Market PB Ratio Median Figure of 11,718 Publicly-Listed Companies 1.87x
NasdaqGS:MDRX PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:MDRX Share Price ÷ Book Value per Share (both in USD)

= 13.86 ÷ 6.37

2.17x

* Primary Listing of Allscripts Healthcare Solutions.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allscripts Healthcare Solutions is good value based on assets compared to the US Healthcare Services industry average.
X
Value checks
We assess Allscripts Healthcare Solutions's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Allscripts Healthcare Solutions has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

MDRX Future Performance

 How is Allscripts Healthcare Solutions expected to perform in the next 1 to 3 years based on estimates from 20 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
33.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Allscripts Healthcare Solutions expected to grow at an attractive rate?
  • Allscripts Healthcare Solutions's earnings growth is expected to exceed the low risk savings rate of 3%.
Growth vs Market Checks
  • Allscripts Healthcare Solutions's earnings growth is expected to exceed the United States of America market average.
  • Allscripts Healthcare Solutions's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqGS:MDRX Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqGS:MDRX Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 20 Analysts 33.6%
NasdaqGS:MDRX Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 20 Analysts 6.3%
United States of America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 27.5%
United States of America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 15.8%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.1%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 6.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGS:MDRX Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 20 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGS:MDRX Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 2,816 547 76 3
2021-12-31 2,642 472 37 3
2020-12-31 2,394 409 -1 9
2019-12-31 2,274 338 -26 20
2018-12-31 2,169 313 2 20
NasdaqGS:MDRX Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-06-30 2,006 237 -6
2018-03-31 1,907 262 -225
2017-12-31 1,806 279 -201
2017-09-30 1,714 257 -210
2017-06-30 1,657 246 -191
2017-03-31 1,618 269 -48
2016-12-31 1,550 269 -26
2016-09-30 1,470 268 -2
2016-06-30 1,432 255 3
2016-03-31 1,397 229 10
2015-12-31 1,386 212 -2
2015-09-30 1,382 180 -21

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Allscripts Healthcare Solutions's earnings are expected to grow significantly at over 20% yearly.
  • Allscripts Healthcare Solutions's revenue is expected to grow by 6.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGS:MDRX Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 20 Analyst Estimates (S&P Global) See Below

All data from Allscripts Healthcare Solutions Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:MDRX Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 0.40 0.40 0.40 1.00
2021-12-31 0.20 0.20 0.20 1.00
2020-12-31 -0.01 0.04 -0.07 3.00
2019-12-31 -0.17 0.20 -0.84 15.00
2018-12-31 0.03 0.34 -0.45 14.00
NasdaqGS:MDRX Past Financials Data
Date (Data in USD Millions) EPS *
2018-06-30 -0.03
2018-03-31 -1.25
2017-12-31 -1.11
2017-09-30 -1.16
2017-06-30 -1.05
2017-03-31 -0.26
2016-12-31 -0.14
2016-09-30 -0.01
2016-06-30 0.02
2016-03-31 0.05
2015-12-31 -0.01
2015-09-30 -0.11

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Allscripts Healthcare Solutions is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Allscripts Healthcare Solutions's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Allscripts Healthcare Solutions has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

MDRX Past Performance

  How has Allscripts Healthcare Solutions performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Allscripts Healthcare Solutions's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Allscripts Healthcare Solutions does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Allscripts Healthcare Solutions's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Allscripts Healthcare Solutions's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Allscripts Healthcare Solutions's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Allscripts Healthcare Solutions Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:MDRX Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 2,006.28 -6.23 549.24 274.85
2018-03-31 1,906.79 -225.44 512.80 240.96
2017-12-31 1,806.34 -201.14 481.07 220.22
2017-09-30 1,714.44 -209.59 451.27 194.58
2017-06-30 1,657.39 -191.19 432.69 188.67
2017-03-31 1,617.82 -47.68 415.46 190.10
2016-12-31 1,549.90 -25.65 388.77 187.91
2016-09-30 1,470.11 -2.01 380.09 186.07
2016-06-30 1,432.20 2.93 362.35 188.63
2016-03-31 1,397.40 9.91 347.30 185.10
2015-12-31 1,386.39 -2.23 339.18 184.79
2015-09-30 1,381.65 -20.73 320.36 180.33
2015-06-30 1,372.56 -41.25 339.35 178.59
2015-03-31 1,372.14 -55.80 345.26 187.24
2014-12-31 1,377.87 -66.45 358.68 192.82
2014-09-30 1,387.95 -84.89 379.72 197.85
2014-06-30 1,372.75 -108.07 384.39 198.69
2014-03-31 1,366.28 -113.18 391.91 197.50
2013-12-31 1,373.06 -104.03 395.10 195.85
2013-09-30 1,373.05 -107.73 383.38 199.28
2013-06-30 1,403.55 -49.42 369.08 190.28
2013-03-31 1,428.68 -18.56 368.19 176.70
2012-12-31 1,446.33 -1.15 384.37 162.16
2012-09-30 1,483.56 49.15 333.76 143.47
2012-06-30 1,486.61 58.91 335.50 131.70
2012-03-31 1,473.48 66.81 344.74 118.22
2011-12-31 1,444.08 73.61 387.57 104.11
2011-09-30 1,489.10 5.05 411.63 102.42

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Allscripts Healthcare Solutions has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Allscripts Healthcare Solutions used its assets less efficiently than the US Healthcare Services industry average last year based on Return on Assets.
  • It is difficult to establish if Allscripts Healthcare Solutions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Allscripts Healthcare Solutions's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Allscripts Healthcare Solutions has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

MDRX Health

 How is Allscripts Healthcare Solutions's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Allscripts Healthcare Solutions's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Allscripts Healthcare Solutions's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Allscripts Healthcare Solutions's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Allscripts Healthcare Solutions's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Allscripts Healthcare Solutions Company Filings, last reported 1 month ago.

NasdaqGS:MDRX Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 1,597.46 1,646.47 135.85
2018-03-31 1,553.80 1,729.35 135.00
2017-12-31 1,591.61 1,577.33 155.84
2017-09-30 1,567.08 1,416.48 104.30
2017-06-30 1,575.10 1,346.53 82.71
2017-03-31 1,587.62 1,327.94 104.39
2016-12-31 1,660.89 1,331.38 95.61
2016-09-30 1,747.91 1,233.12 77.25
2016-06-30 1,718.51 1,197.25 90.66
2016-03-31 1,389.27 599.82 100.12
2015-12-31 1,419.07 625.63 116.87
2015-09-30 1,395.58 655.04 91.40
2015-06-30 1,391.54 662.59 76.54
2015-03-31 1,278.09 572.69 88.48
2014-12-31 1,284.22 566.69 53.17
2014-09-30 1,282.83 587.25 37.35
2014-06-30 1,299.12 558.99 39.25
2014-03-31 1,307.62 549.19 41.58
2013-12-31 1,318.15 561.94 62.95
2013-09-30 1,331.03 544.85 60.79
2013-06-30 1,367.58 545.07 71.98
2013-03-31 1,334.29 552.15 92.23
2012-12-31 1,284.34 443.54 103.96
2012-09-30 1,299.12 461.67 93.67
2012-06-30 1,280.74 490.96 120.37
2012-03-31 1,489.54 345.66 175.68
2011-12-31 1,476.72 369.90 157.75
2011-09-30 1,438.90 380.41 84.78
  • Allscripts Healthcare Solutions's level of debt (103.1%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (39.9% vs 103.1% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Allscripts Healthcare Solutions has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Allscripts Healthcare Solutions has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 46.8% per year.
X
Financial health checks
We assess Allscripts Healthcare Solutions's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Allscripts Healthcare Solutions has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

MDRX Dividends

 What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Allscripts Healthcare Solutions dividends.
If you bought $2,000 of Allscripts Healthcare Solutions shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Allscripts Healthcare Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Allscripts Healthcare Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGS:MDRX Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 20 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 0.4%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 5588 Stocks 2.9%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqGS:MDRX Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31 0.00 3.00
2019-12-31 0.00 4.00
2018-12-31 0.00 4.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Allscripts Healthcare Solutions has not reported any payouts.
  • Unable to verify if Allscripts Healthcare Solutions's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Allscripts Healthcare Solutions's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Allscripts Healthcare Solutions has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Allscripts Healthcare Solutions's dividends in 3 years as they are not expected to pay a notable for United States of America.
X
Income/ dividend checks
We assess Allscripts Healthcare Solutions's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Allscripts Healthcare Solutions afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Allscripts Healthcare Solutions has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

MDRX Management

 What is the CEO of Allscripts Healthcare Solutions's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Paul Black, image provided by Google.
Paul Black
COMPENSATION $7,724,584
AGE 60
TENURE AS CEO 5.7 years
CEO Bio

Mr. Paul M. Black has been the Chief Executive Officer of Allscripts Healthcare Solutions, Inc. since December 19, 2012. Mr. Black serves as an Adjunct Professor of Businss at the University of Missouri – Kansas City. He served as the President of Allscripts Healthcare Solutions, Inc. from December 19, 2012 to October 2015. Mr. Black served as a Senior Advisor at New Mountain Capital, LLC. He served as an Operating Executive at Genstar Capital, LLC. He spent 13 years at Cerner Corporation, where Mr. Black served as the Chief Sales Officer, an Executive Vice President of United States Client Organization, from 2003 to August 31, 2007 and served as the Chief Operating Officer, from February 2005 to August 31, 2007, with responsibility for operations and sales, technologies, managed services and intellectual property organizations. He joined Cerner Corp. in March of 1994 as a Regional Vice President. Mr. Black served as Senior Vice President and the Chief Sales Officer, since June 1998 and Executive Vice President, since September 2000. He served a number of positions for 12 years at International Business Machines Corporation (IBM), from 1982 to 1994, including as a Sales and Professional Services Branch Executive. Mr. Black has been the Chairman of Aris Teleradiology LLC, since December 2011. He serves as Director of Saepio Technologies, Inc. and eResearch Technology, Inc. Mr. Black serves on the Board of Directors of Biotronic NeuroNetwork. Mr. Black has been a Director of Allscripts Healthcare Solutions, Inc. since May 16, 2012, Netsmart Technologies, Inc. since January 31, 2011. He serves as a Member of the Board of Directors of Truman Medical Center, Inc. since 2001, Inmar Holdings Inc., Saepio Technologies, Inc., and Connextions, Inc. He served as a Director of Haemonetics Corporation since January 26, 2011. Mr. Black served as a Member of Chief Executive Officer Advisory Board of Great Point Partners, LLC, since 2011. He served as the Chairman of Truman Medical Center, Inc. Mr. Black has an MBA with emphasis in Marketing and Industrial Relations from the University of Iowa and a B.S. from Iowa State University.

CEO Compensation
  • Paul's compensation has increased whilst company is loss making.
  • Paul's compensation is higher than average for a company of this size and profit level.
Management Team Tenure

Average tenure and age of the Allscripts Healthcare Solutions management team in years:

2.3
Average Tenure
53
Average Age
  • The tenure for the Allscripts Healthcare Solutions management team is about average.
Management Team

Paul Black

TITLE
CEO & Director
COMPENSATION
$8M
AGE
60
TENURE
5.7 yrs

Rick Poulton

TITLE
President
COMPENSATION
$5M
AGE
53
TENURE
2.8 yrs

Dennis Olis

TITLE
Chief Financial Officer
COMPENSATION
$2M
AGE
55
TENURE
1.3 yrs

Brian Farley

TITLE
Executive VP
COMPENSATION
$2M
AGE
48
TENURE
1 yrs

Lisa Khorey

TITLE
Executive VP & Chief Client Delivery Officer
COMPENSATION
$2M
AGE
51
TENURE
1.8 yrs

Danielle Protexter

TITLE
Associate Manager

Stephen Shulstein

TITLE
Vice President of Investor Relations
TENURE
0.2 yrs

Paul Lewis

TITLE
Senior Vice President of Sales & Services and Acting General Manager
TENURE
11.6 yrs

Steve Lalonde

TITLE
Senior Vice President

David Chambers

TITLE
Managing Director of Asia Pacific
TENURE
4.8 yrs
Board of Directors Tenure

Average tenure and age of the Allscripts Healthcare Solutions board of directors in years:

2.7
Average Tenure
61.5
Average Age
  • The average tenure for the Allscripts Healthcare Solutions board of directors is less than 3 years, this suggests a new board.
Board of Directors

Michael Klayko

TITLE
Chairman of the Board
COMPENSATION
$386K
AGE
63
TENURE
4.4 yrs

Paul Black

TITLE
CEO & Director
COMPENSATION
$8M
AGE
60
TENURE
6.6 yrs

David Stevens

TITLE
Director
COMPENSATION
$310K
AGE
64
TENURE
6.6 yrs

Greg Garrison

TITLE
Director
COMPENSATION
$313K
AGE
64
TENURE
3.1 yrs

Jon Judge

TITLE
Director
COMPENSATION
$279K
AGE
64
TENURE
2.3 yrs

Yancey Spruill

TITLE
Director
COMPENSATION
$279K
AGE
50
TENURE
2.3 yrs

Dave Stevens

TITLE
Director
COMPENSATION
$277K
AGE
55
TENURE
2.3 yrs

Mara Aspinall

TITLE
Director
COMPENSATION
$241K
AGE
56
TENURE
1.3 yrs
Recent Insider Trading
  • No 3 month insider trading information.
Who owns this company?
X
Management checks
We assess Allscripts Healthcare Solutions's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap and profit (greater than 0.5% of the company's profit + 0.03% of market cap)? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Allscripts Healthcare Solutions has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

MDRX News

External News
Loading...
Simply Wall St News

Is Allscripts Healthcare Solutions Inc's (NASDAQ:MDRX) Balance Sheet Strong Enough To Weather A Storm?

Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) with a market-capitalization of US$2.39b, rarely draw their attention. … Remember this is a very top-level look that focuses exclusively on financial health, so I recommend a deeper analysis. … View our latest analysis for Allscripts Healthcare Solutions

Simply Wall St -

Is Allscripts Healthcare Solutions Inc's (NASDAQ:MDRX) CEO Paid At A Competitive Rate?

Understanding how CEOs are incentivised to run and grow their company is an important aspect of investing in a stock. … This is because, if incentives are aligned, more value is created for shareholders which directly impacts your returns as an investor. … CEOs leading companies of similar size and profitability

Simply Wall St -

Estimating The Intrinsic Value Of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)

Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) as an investment opportunity. … by projecting its future cash flows and then discounting them to today's value. … If you are reading this and its not June 2018 then I highly recommend you check out the latest calculation for Allscripts Healthcare Solutions by following the link below.

Simply Wall St -

Investors In Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Are Paying Above The Intrinsic Value

In this article I am going to calculate the intrinsic value of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by estimating the company's future cash flows and discounting them to their present value. … 5-year cash flow forecast 2018 2019 2020 2021 2022 Levered FCF ($, Millions) $147.68 $189.43 $208.77 $247.95 $266.35 Source Analyst x5 Analyst x4 Analyst x3 Analyst x2 Analyst x2 Present Value Discounted @ 12.92% $130.78 $148.55 $144.98 $152.49 $145.06 Present Value of 5-year Cash Flow (PVCF)= $722 After calculating the present value of future cash flows in the intial 5-year period we need to calculate the Terminal Value, which accounts for all the future cash flows beyond the first stage. … Terminal Value (TV) = FCF2022 × (1 + g) ÷ (r – g) = $266 × (1 + 2.5%) ÷ (12.9% – 2.5%) = $2,611 Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = $2,611 / ( 1 + 12.9%)5 = $1,422 The total value is the sum of cash flows for the next five years and the discounted terminal value, which results in the Total Equity Value, which in this case is $2,144.

Simply Wall St -

What Investors Should Know About Allscripts Healthcare Solutions Inc's (MDRX) Financial Strength

See our latest analysis for MDRX Is MDRX’s level of debt at an acceptable level? … In the case of MDRX, the debt-to-equity ratio is 90.39%, which indicates that the company is holding a high level of debt relative to its net worth. … To assess this, I compare MDRX's cash and other liquid assets against its upcoming debt.

Simply Wall St -

Is There Now An Opportunity In Allscripts Healthcare Solutions Inc (MDRX)?

Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at MDRX future expectations. … MDRX’s optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. … If you believe MDRX should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable.

Simply Wall St -

An Intrinsic Value Calculation For Allscripts Healthcare Solutions Inc (MDRX) Shows Investors Are Overpaying

Using the most recent financial data, I am going to take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to their present value. … 5-year cash flow estimate 2017 2018 2019 2020 2021 Levered FCF (USD, Millions) $112.87 $160.10 $212.05 $229.50 $247.10 Source Analyst x6 Analyst x5 Analyst x2 Analyst x2 Analyst x2 Present Value Discounted @ 14.88% $98.25 $121.31 $139.86 $131.76 $123.49 Present Value of 5-year Cash Flow (PVCF)= $615 After calculating the present value of future cash flows in the intial 5-year period we need to calculate the Terminal Value, which accounts for all the future cash flows beyond the first stage. … Terminal Value (TV) = FCF2021 × (1 + g) ÷ (r – g) = $247 × (1 + 2.5%) ÷ (14.9% – 2.5%) = $2,040 Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = $2,040 / ( 1 + 14.9%)5 = $1,020 The total value, or equity value, is then the sum of the present value of the cash flows, which in this case is $1,634.

Simply Wall St -

MDRX Company Info

Map
Description

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company’s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company’s Netsmart segment operates in and provides software and technology solutions to the health and human services, and post-acute sectors of health care. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Details
Name: Allscripts Healthcare Solutions, Inc.
MDRX
Exchange: NasdaqGS
Founded: 1986
$2,435,807,268
174,609,840
Website: http://www.allscripts.com
Address: Allscripts Healthcare Solutions, Inc.
222 Merchandise Mart Plaza,
Suite 2024,
Chicago,
Illinois, 60654,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS MDRX Common Shares Nasdaq Global Select US USD 14. Mar 2006
DB AL21 Common Shares Deutsche Boerse AG DE EUR 14. Mar 2006
Number of employees
Current staff
Staff numbers
8,900
Allscripts Healthcare Solutions employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2018/08/15 21:11
End of day share price update: 2018/08/15 00:00
Last estimates confirmation: 2018/08/06
Last earnings update: 2018/06/30
Last annual earnings update: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.